Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease [2]

New England Journal of Medicine

Volumn 341, Issue 24, 1999, Pages 1853-1855

  Cohen, D J ^a   Carrozza, J P ^a   Baim, D S ^a   Ricciardi, M J ^a   Davidson, C J ^a   Bloom, J M ^a   Pitt, B ^a   Waters, D ^a   Brown, W V ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN;

CORONARY ARTERY DISEASE; HUMAN; INTERMETHOD COMPARISON; LETTER; MORTALITY; PRIORITY JOURNAL; RESTENOSIS; RISK MANAGEMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MYOCARDIAL ISCHEMIA; PYRROLES; RECURRENCE;

EID: 0033540013     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199912093412415     Document Type: Letter

References (0)